AstraZeneca Can Make Up To 1B Covid-19 Vaccine Doses, Signs First Supply Pacts
Gilead, Galapagos claim PhIIb/III win for filgotinib in ulcerative colitis — which pales in comparison to rivals
Macro Briefing | 21 May 2020
DC Strength Could Power Gains for Nvidia (NVDA) Stock, Says Analyst
Gilead Still Holds the Winning Hand, Says 5-Star Analyst
Top Banking Regulator Joseph Otting To Resign
Coronavirus – weekly update – 20 May 2020
Using machine learning to estimate COVID-19’s seasonal cycle
Opportunities in EM Stocks Emerge
Chart of the WeekTracking the $9 Trillion Global Fiscal Support to Fight COVID-19
A little-known biotech running low on cash looks to get its own $100M IPO from pandemic market
Global Startup Survey Reveals COVID-19 Caused Fundings To Drop
Macro Briefing | 20 May 2020
Fed Funds Futures No Longer Imply Negative Rates
Zoom Suspends Free China Service As Trade Tensions Intensify
Aldeyra Explodes 30% After-Hours Ahead Of Covid-19 Update Today
China Leaves Rates Unchanged. Japan Machinery Orders Rebound
Prellis Bio’s Externalized Human Immune System rapidly generates 300 SARS-CoV2 antibodies
Ring, Ring, Hündchen
Moderna stock volatile amid work on coronavirus vaccine
Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process
Donald Trump Wants To Cut The Funding For The WHO
Coronavirus seemingly tamed, Where’s the bottom?
Aurora Cannabis (ACB) Has a Positive Outlook, But the Stock Needs to Settle Down
Partial measures compromise effectiveness of efforts to combat COVID-19
Abbreviated coronavirus dashboard for May 19: testing improvement continues
iQIYI Sinks 4% As Online Ad-Revenue Falls Sharply
Daily market commentary: COVID-19 vaccination rumours diminishing investors’ appetite for safe haven assets
Carvana Sinks 7% In Pre-Market On Public Offering Of 5M Shares
Baidu Pops 8% After-Hours On Strong Earnings Beat
